[HTML][HTML] High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast …
C Ahlin, C Lundgren, E Embretsén-Varro… - Breast cancer research …, 2017 - Springer
Purpose Cyclin D1 has a central role in cell cycle control and is an important component of
estrogen regulation of cell cycle progression. We have previously shown that high cyclin D …
estrogen regulation of cell cycle progression. We have previously shown that high cyclin D …
Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact
C Nilsson, I Johansson, C Ahlin, S Thorstenson… - Acta …, 2013 - Taylor & Francis
Background. Male breast cancer (MBC) is an uncommon disease and there is limited information
on the prognostic impact of routinely used clinicopathological parameters. Material and …
on the prognostic impact of routinely used clinicopathological parameters. Material and …
Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population‐based lymph node negative breast cancer cohort
E Niméus‐Malmström, A Koliadi, C Ahlin… - … journal of cancer, 2010 - Wiley Online Library
A large proportion of women with lymph node negative breast cancer do not benefit from
chemotherapy. Proliferation markers have been shown to recognize patients at high risk for …
chemotherapy. Proliferation markers have been shown to recognize patients at high risk for …
[HTML][HTML] Natural history of recurrences in endometrial carcinoma
B Sorbe, C Juresta, C Ahlin - Oncology letters, 2014 - spandidos-publications.com
The aim of the present study was to evaluate the natural history of endometrial cancer
recurrences with regard to predictive and prognostic factors. Between 1990 and 1999, 100 …
recurrences with regard to predictive and prognostic factors. Between 1990 and 1999, 100 …
Ki67 and cyclin A as prognostic factors in early breast cancer. What are the optimal cut‐off values?
C Ahlin, K Aaltonen, RM Amini, H Nevanlinna… - …, 2007 - Wiley Online Library
Aims: To find the optimal cut‐off values for cyclin A and Ki67 in early breast cancer tumours
and to evaluate their prognostic values. Methods and results: Tissue microarray (TMA) slides …
and to evaluate their prognostic values. Methods and results: Tissue microarray (TMA) slides …
Decline, adaptation or transformation: new perspectives on demographic change in resource peripheries in Australia and Sweden
…, DA Carson, R Porter, CY Ahlin… - Comparative …, 2016 - comparativepopulationstudies.de
Many sparsely populated resource peripheries in developed countries are perceived to suffer
from periods of demographic decline due to loss of employment opportunities and services…
from periods of demographic decline due to loss of employment opportunities and services…
[HTML][HTML] The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative …
M Klintman, C Strand, C Ahlin, S Beglerbegovic… - PLoS …, 2013 - journals.plos.org
Proliferation, either as the main common denominator in genetic profiles, or in the form of
single factors such as Ki67, is recommended for clinical use especially in estrogen receptor-…
single factors such as Ki67, is recommended for clinical use especially in estrogen receptor-…
Genetic alterations in the K-Ras gene influence the prognosis in patients with cervical cancer treated by radiotherapy
P Wegman, C Ahlin, B Sorbe - International Journal of Gynecologic …, 2011 - ijgc.bmj.com
Introduction: A high incidence of K-Ras mutations has been identified in a variety of human
cancers, especially in codon 12, 13, and 61. Nevertheless, the presence of K-Ras mutations …
cancers, especially in codon 12, 13, and 61. Nevertheless, the presence of K-Ras mutations …
[HTML][HTML] High proliferation is associated with inferior outcome in male breast cancer patients
C Nilsson, A Koliadi, I Johansson, C Ahlin… - Modern Pathology, 2013 - Elsevier
Assessment of proliferation is important in female breast cancer and individual treatment
decisions are based upon its results, especially in the luminal subgroups. Gene expression …
decisions are based upon its results, especially in the luminal subgroups. Gene expression …
[HTML][HTML] Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
M Grönberg, C Ahlin, Y Naeser, ET Janson… - PloS one, 2017 - journals.plos.org
Ghrelin and obestatin are gastrointestinal peptides, encoded by the same preproghrelin
gene. Both are expressed in breast cancer tissue and ghrelin has been implicated in breast …
gene. Both are expressed in breast cancer tissue and ghrelin has been implicated in breast …